The most recent guest on First Rounders is Grace Colón, president and CEO of InCarda Therapeutics. She did her graduate work at MIT, where she was mentored by Greg Stephanopoulos and Anthony Sinskey, and then went to work at McKinsey & Co. That began her career path toward biotech, including stints at Affymetrix (later bought by Thermo Fisher), and Gilead Sciences (currently doing its part against covid19).
Subscribe to the Topic
Life Sciences > Biological Sciences > Biotechnology
A monthly journal covering the science and business of biotechnology, with new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences.